When people use sunscreen heavily, tiny amounts of its chemicals—avobenzone and oxybenzone—can get into their blood, and scientists can measure these tiny amounts, though they’re way too small to see or feel.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim reports measured concentrations from a controlled human study under defined conditions (maximal usage), which is a descriptive, quantitative observation. The use of specific concentration ranges and the phrase 'can be detected' aligns with empirical data from pharmacokinetic studies. The claim does not imply harm or benefit, only detection, making a definitive verb appropriate. The values are precise and bounded, suggesting they are drawn from actual measurements.
More Accurate Statement
“After maximal usage conditions, avobenzone and oxybenzone, active ingredients in commercial sunscreen products, are absorbed into the human bloodstream and can be detected in plasma at measurable concentrations ranging from 0.20–12.00 ng/mL for avobenzone and 0.40–300.00 ng/mL for oxybenzone.”
Context Details
Domain
medicine
Population
human
Subject
Avobenzone and oxybenzone, active ingredients in commercial sunscreen products
Action
can be detected
Target
in human plasma after maximal usage conditions, with measurable concentrations ranging from 0.20–12.00 ng/mL for avobenzone and 0.40–300.00 ng/mL for oxybenzone
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Scientists tested people who used sunscreen as much as possible, and found the chemicals avobenzone and oxybenzone in their blood—exactly at the levels the claim says they should be.